Structural basis for recognition of CD20 by therapeutic antibody Rituximab
Du, J., Wang, H., Zhong, C., Peng, B., Zhang, M., Li, B., Huo, S., Guo, Y., Ding, J.(2007) J Biol Chem 282: 15073-15080
- PubMed: 17395584 
- DOI: 10.1074/jbc.M701654200
- Primary Citation of Related Structures:  
2OSL - PubMed Abstract: 
Rituximab is a widely used monoclonal antibody drug for treating certain lymphomas and autoimmune diseases. To understand the molecular mechanism of recognition of human CD20 by Rituximab, we determined the crystal structure of the Rituximab Fab in complex with a synthesized peptide comprising the CD20 epitope (residues 163-187) at 2 ...